Yu, T.; Cao, J.; Alaa Eddine, M.; Moustafa, M.; Mock, A.; Erkut, C.; Abdollahi, A.; Warta, R.; Unterberg, A.; Herold-Mende, C.;
et al. Receptor-Tyrosine Kinase Inhibitor Ponatinib Inhibits Meningioma Growth In Vitro and In Vivo. Cancers 2021, 13, 5898.
https://doi.org/10.3390/cancers13235898
AMA Style
Yu T, Cao J, Alaa Eddine M, Moustafa M, Mock A, Erkut C, Abdollahi A, Warta R, Unterberg A, Herold-Mende C,
et al. Receptor-Tyrosine Kinase Inhibitor Ponatinib Inhibits Meningioma Growth In Vitro and In Vivo. Cancers. 2021; 13(23):5898.
https://doi.org/10.3390/cancers13235898
Chicago/Turabian Style
Yu, Tao, Junguo Cao, Montadar Alaa Eddine, Mahmoud Moustafa, Andreas Mock, Cihan Erkut, Amir Abdollahi, Rolf Warta, Andreas Unterberg, Christel Herold-Mende,
and et al. 2021. "Receptor-Tyrosine Kinase Inhibitor Ponatinib Inhibits Meningioma Growth In Vitro and In Vivo" Cancers 13, no. 23: 5898.
https://doi.org/10.3390/cancers13235898
APA Style
Yu, T., Cao, J., Alaa Eddine, M., Moustafa, M., Mock, A., Erkut, C., Abdollahi, A., Warta, R., Unterberg, A., Herold-Mende, C., & Jungwirth, G.
(2021). Receptor-Tyrosine Kinase Inhibitor Ponatinib Inhibits Meningioma Growth In Vitro and In Vivo. Cancers, 13(23), 5898.
https://doi.org/10.3390/cancers13235898